📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Personalized neoantigen viro-immunotherapy platform for triple-negative breast cancer. (2023)

First Author: Brito Baleeiro R

Attributed to: Pre-clinical development for IND application of a novel systemically deliverable oncolytic Vaccinia virus for treatment of pancreatic cancer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/jitc-2023-007336

PubMed Identifier: 37586771

Publication URI: http://europepmc.org/abstract/MED/37586771

Type: Journal Article/Review

Volume: 11

Parent Publication: Journal for immunotherapy of cancer

Issue: 8

ISSN: 2051-1426